Did you know?
ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.
Free Newsletter
Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!
Free Report
The 7th ChinaBio® Investor Forum granted “Most...
Fosun Pharma will raise up to 635 million RMB ($93.4...
Guilin Sanjin Pharma led the parade of China life science...
The world of China life science is...
Pfizer has built a Shanghai-based business development...
Suzhou Natong BioNanotechnology signed a funding...
CMOs will continue their 20% CAGR to $2 billion in 2010,...
Tigermed Consulting formed a China clinical CRO alliance...
Shenzhen Hepalink Pharma, a heparin drugmaker, staged a...
China is close to finalizing a draft proposal of a...
ChinaBio® News
Greg Scott Interviewed at BIO-Europe Spring
How to bring your China assets to China in 8 minutes
"Mr. Bio in China."
Mendelspod Interview
Multinational pharma held to a higher standard in China
